爱能罗格列酮片_说明书（Love Rosiglitazone Tablets _ instructions）.doc

爱能罗格列酮片_说明书（Love Rosiglitazone Tablets _ instructions） [drug name] general name: Rosiglitazone Tablets Chinese Pinyin: lvgelietongpian [commodity type] prescription drug (RX) [approval number] [ingredients] rosiglitazone [character] this product is white [indication] used in type 2 diabetes mellitus. A single dose of this product, coupled with diet control and exercise, can control blood sugar in type 2 diabetes patients. For diet control and exercise plus this or a single antidiabetic drug and type 2 diabetes mellitus with poor glycemic control, this product may be used in combination with metformin or sulfonylurea. For patients who take the most recommended dose of metformin or sulfonylurea and have poor glycemic control, this product should not be used as an alternative to antidiabetic drugs, but should be applied on the basis of it. Diet control is the first treatment for type 2 diabetes mellitus. Caloric restriction, weight loss, and exercise increase insulin sensitivity, so that it is not only a basic treatment for type 2 diabetes, but also important for effective maintenance of the efficacy of the drug. Control of blood sugar control, such as infection, should be controlled prior to taking this product. [Specification] 4mg*14s [usage] the treatment of diabetes should be individualized, the starting dosage of this product is 4mg / day, 1 times a day, 4 tablets each time. After 12 weeks of treatment, if the fasting blood glucose control is not ideal, can be added to 8 mg / day, once a day or two times (morning and evening l times). The hypoglycemic effects of different dosages and usages are detailed in the clinical and clinical trials section. This product can be taken on an empty stomach or at table. Single drug treatment: the initial dosage of this product is 4 mg / day, 1 times a day, 4 tablets each time. Clinical trials show that taking 4 mg / twice per day, 2 times more significantly reduce the fasting plasma glucose and HbAlc levels. In combina